Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding PSIL?
Track your performance easily
PSIL Price & Analysis
PSIL ETF Chart & Stats
Day’s Range― - ―
52-Week Range$7.14 - $17.00
Previous Close$12
VolumeN/A
Average Volume (3M)26.91K
AUM6.71M
NAV12.02
Expense Ratio0.99%
Holdings Count24
Beta1.31
Inception DateSep 15, 2021
Last Dividend Ex-Date
Sep 23, 2024Dividend Yield
0.11 (0.9%)Shares Outstanding549,976
Standard Deviation0.16
10 Day Avg. Volume17,508
30 Day Avg. Volume26,911
Alpha-0.05
AdvisorShares Psychedelics ETF (PSIL) Fund Flow Chart
AdvisorShares Psychedelics ETF (PSIL) 1 year Net Flows: -$3M
PSIL ETF News
PremiumCompany Announcements
NRX Pharmaceuticals Strengthens Leadership with New CFO AppointmentPremiumCompany Announcements
GH Research Q3 2024 Results and Clinical UpdatesPSIL ETF FAQ
What was PSIL’s price range in the past 12 months?
PSIL lowest ETF price was $7.14 and its highest was $17.00 in the past 12 months.
What is the AUM of PSIL?
As of Nov 20, 2024 The AUM of PSIL is 6.71M.
Is PSIL overvalued?
According to Wall Street analysts PSIL’s price is currently Undervalued.
Does PSIL pay dividends?
PSIL pays a Annually dividend of $0.11 which represents an annual dividend yield of 0.9%. See more information on PSIL dividends here
How many shares outstanding does PSIL have?
PSIL has 549,976 shares outstanding.
Which hedge fund is a major shareholder of PSIL?
Currently, no hedge funds are holding shares in PSIL
Top 10 Holdings
MUTUAL FUND (OTHER)
12.23%
Mind Medicine Inc.
11.55%
Cybin, Inc.
8.43%
Atai Life Sciences N.V.
7.19%
Gh Research Plc
5.95%
Compass Pathways Plc
5.69%
Quantum Biopharma Ltd. Subordinate Voting Shares Class B
5.59%
Alkermes plc
5.33%
Nrx Pharmaceuticals, Inc.
5.30%
Intra-Cellular Therapies
4.38%
Total71.63%
ETF Description
AdvisorShares Psychedelics ETF
PSIL is actively managed to provide exposure to the emerging global psychedelics industry.